FENC stock

Fennec Pharmaceuticals Inc (FENC) earnings · rev $44.6M

These earnings events as JSON? API free 100/day

Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.

This FENC earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported FENC revenue for 2025-12-31 was $44.6M. Net income was -$9.7M. Revenue was down 6.1% from 2024-12-31 to 2025-12-31. FENC currently screens at market cap $302.2M.

When the next FENC 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was down 6.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.

Not investment advice. Full FENC research stays on the stock page; the tape stays on the quote page.

FENC earnings FAQ

What are FENC's latest revenue and net income?

Latest cached Fennec Pharmaceuticals Inc (FENC) revenue for Dec 31, 2025 was $44.6M. Net income was -$9.7M. Statements: https://lician.com/financials/fenc

What is FENC's latest diluted EPS?

Latest cached Fennec Pharmaceuticals Inc (FENC) diluted EPS for Dec 31, 2025 was -$0.34.

What period does the latest FENC earnings print cover?

The latest cached Fennec Pharmaceuticals Inc (FENC) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

How did FENC revenue change from the prior cached period?

Cached Fennec Pharmaceuticals Inc (FENC) revenue was down 6.1% from $47.5M (Dec 31, 2024) to $44.6M (Dec 31, 2025). Statements: https://lician.com/financials/fenc

Where are FENC earnings listed?

Cached earnings facts for Fennec Pharmaceuticals Inc (FENC) are listed at https://lician.com/earnings/fenc. Statements: https://lician.com/financials/fenc

Not investment advice.

Full FENC analysis